FXG Advanced Viroblock Face Mask -Team Craik
Support the 2020 Scottish Junior Champions and World Junior Bronze medalists by buying their very own custom face mask. The mask is white and features the Tream Craik logo in blue and grey.
For every sale we will give the team £5 and help to fund their 20/21 Season.
Using the very latest fabric treatment from leading Swiss technology brand HEIQ our mask will give added confidence to prevent the spread of any virus.
This 3-part mask is engineered for performance, tailored for comfort, and using advanced Viroblock treatment for maximum protection. Each mask is supplied with 2 removeable filters.
Detail and specification:
Standard mask size: Adult: 20cm x 15cm (8 inches x 6 inches)
Elasticated straps for comfort with plastic toggles for adjustment.
Fabric composition: Outer Fabric: 94%polyester fibre, 6% spandex, Inner Fabric: Polyamide / Polypropylene mix
Washing: For best results wash in warm or hot water (at least 40°C/104°F).
Relive some famous games from world curling with this special edition face covering.
Please visit our dedicated face mask website to see our full collection.
* These masks are not medical devices or personal protective equipment (PPE). They are for personal use and are not intended for use by health care professionals or for use in hospitals or health care facilities. These face masks should not be used in any surgical setting or where significant exposure to liquid, bodily or other hazardous fluids may be expected, a clinical setting where the infection risk level through inhalation exposure is high, the presence of a high intensity heat source or flammable gas.
** There are seven types of human coronavirus: 229E and COVID-19 are two of them. The different types of coronaviruses are highly similar in their membrane structure. The membrane is what our vesicle and silver technology in HeiQ Viroblock NPJ03 targets in order to achieve reduction in the viruses’ infectivity. Our technology has also been tested against Influenza types H1N1, H5N1, H7N9, and Respiratory Syncytial Virus (RSV) and demonstrated significantly improved reduction of virus infectivity. Regarding the efficacy of our technology on COVID-19, a direct test has not yet been carried out.